Modifying the sugar icing on the transplantation cake
Open accessThe DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
As a transplant surgeon, my interest in glycobiology began through my research into ABO-incompatible allotransplantation, and grew when my goal became overcoming the shortage of organs from deceased human donors by the transplantation of pig organs into patients with terminal organ failure (xenotransplantation/cross-species transplantation). The major target for human "natural" (preformed) anti-pig antibodies is galactose-α(1,3)-galactose (the "Gal" epitope), which is expressed on many pig cells, including the vascular endothelium. The binding of human IgM and IgG antibodies to Gal antigens initiates the process of hyperacute rejection, resulting in destruction of the pig graft within minutes or hours. This major barrier has been overcome by the production of pigs in which the gene for the enzyme α(1,3)-galactosyltransferase (GT) has been deleted by genetic engineering, resulting in GT knockout (GTKO) pigs. The two other known carbohydrate antigenic targets on pig cells for human anti-pig antibodies are (i) the product of the cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) gene, i.e., N-glycolylneuraminic acid, and (ii) the product of the β1,4 N-acetylgalactosaminyltransferase gene, i.e., the Sd(a) antigen. Expression of these two has also been deleted in pigs. These genetic manipulations, together with others directed to overcoming primate complement and coagulation activation (the latter of which also relates to glycobiology) have contributed to the prolongation of pig graft survival in nonhuman primate recipients to many months rather than a few minutes. Clinical trials of the transplantation of pig cells are already underway and transplantation of pig organs may be expected within the relatively near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“glycans like ɑ -Gal and the nonhuman sialic acid Neu5Gc represent the major xenoantigens that must be bypassed, to pursue the goal of xeno- (pig organ) transplantation into humans. In pursuit of this dif fi cult goal, ɑ -Galand Neu5Gc-double null pigs have recently been generated (980 -983).”
From Biological roles of glycans (2017) · cites this paper as [983]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheep cloned by nuclear transfer from a cultured cell line
Campbell, K. H. S., McWhir, J., Ritchie, W. A., & Wilmut, I. (1996) · Nature · doi:10.1038/380064a0 · Cited by 1,844 · cited 3×
“1996), but knockout of the GT gene in pigs only became possible after the development of the technology that produced the world’s first cloned mammal, the sheep known as “Dolly” (Campbell et al. 1996) and, subsequently, the first cloned pig (Polejaeva et al.”
BackgroundCloned pigs produced by nuclear transfer from adult somatic cells
Polejaeva, I. A., Chen, S.-H., Vaught, T. D., Page, R. L., Mullins, J., Ball, S., Dai, Y., Boone, J., Walker, S., Ayares, D. L., et al. (2000) · Nature · doi:10.1038/35024082 · Cited by 1,254 · cited 2×
“1996) and, subsequently, the first cloned pig (Polejaeva et al. 2000).”
BackgroundProduction of α1,3-Galactosyltransferase-Deficient Pigs
Phelps, C. J., Koike, C., Vaught, T. D., Boone, J., Wells, K. D., Chen, S.-H., Ball, S., Specht, S. M., Polejaeva, I. A., Monahan, J. A., et al. (2003) · Science · doi:10.1126/science.1078942 · Cited by 1,112 · cited 1×
“The first GTKO pigs did not become available until 2003 (Phelps et al. 2003; Kolber-Simonds et al. 2004), and my colleagues and I at the TBRCwere the first to test the transplantation of organs from these pigs in immunosuppressed baboons (Kuwaki et al. 2005; Tseng et al. 2005a; Yamada et al. 2005;…”
BackgroundGalili, U., Shohet, S. B., Kobrin, E., Stults, C. L., & Macher, B. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77900-9 · Cited by 817
Kuwaki, K., Tseng, Y.-L., Dor, F. J. M. F., Shimizu, A., Houser, S. L., Sanderson, T. M., Lancos, C. J., Prabharasuth, D. D., Cheng, J., Moran, K., et al. (2005) · Nature Medicine · doi:10.1038/nm1171 · Cited by 694 · cited 1×
“…until 2003 (Phelps et al. 2003; Kolber-Simonds et al. 2004), and my colleagues and I at the TBRCwere the first to test the transplantation of organs from these pigs in immunosuppressed baboons (Kuwaki et al. 2005; Tseng et al. 2005a; Yamada et al. 2005; Hisashi et al. 2008; Shimizu et al. 2008).”
BackgroundSelf-citationGalili, U. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90261-i · Cited by 659 · cited 1×
“Although Galili had carried out several studies on the nature of anti-Gal antibodies, he had not directed his attention towards xenotransplantation before this time (Galili 1993).”
BackgroundGood, A. H., Cooper, D. K. C., Malcolm, A. J., Ippolito, R. M., Koren, E., Neethling, F. A., YE, Y., Zuhdi, N., & Lamontagne, L. R. (1992) · PubMed · Cited by 639
Self-citationA unique natural human IgG antibody with anti-alpha-galactosyl specificity.
Galili, U., Rachmilewitz, E. A., Peleg, A., & Flechner, I. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1519 · Cited by 631 · cited 2×
“I had never heard of Gal previously, but the Chembiomed team informed me that they had prior knowledge of it as they had carried out some work for Uri Galili, who had identified that all mammals below Old World monkeys express Gal whereas Old World nonhuman primates and humans lack the requisite enzyme α(1,3)galactosy…”
BackgroundYamada, K., Yazawa, K., Shimizu, A., Iwanaga, T., Hisashi, Y., Nuhn, M., O'Malley, P., Nobori, S., Vagefi, P. A., Patience, C., et al. (2005) · Nature Medicine · doi:10.1038/nm1172 · Cited by 610 · cited 2×
“2004), and my colleagues and I at the TBRC were the first to test the transplantation of organs from these pigs in immunosuppressed baboons (Kuwaki et al. 2005; Tseng et al. 2005a; Yamada et al. 2005; Hisashi et al. 2008; Shimizu et al. 2008).”
BackgroundSelf-citationAnti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.
Sandrin, M. S., Vaughan, H. A., Dabkowski, P. L., & McKenzie, I. F. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11391 · Cited by 605 · cited 1×
“Others soon confirmed our conclusion (Sandrin et al. 1993).”
Galili, U., Mandrell, R. E., Hamadeh, R. M., Shohet, S. B., & Griffiss, J. M. (1988) · Infection and Immunity · doi:10.1128/iai.56.7.1730-1737.1988 · Cited by 548 · cited 3×
“Galili had put forward the hypothesis that humans, apes, and Old World monkeys develop anti-Gal antibodies (so called ‘natural’ or ‘preformed’ antibodies) during infancy as a ‘defensive’ response to the colonization of their gastrointestinal tracts by microorganisms and viruses that express Gal (Galili et al. 1988a).”
BackgroundKolber-Simonds, D., Lai, L., Watt, S. R., Denaro, M., Arn, S., Augenstein, M. L., Betthauser, J., Carter, D. B., Greenstein, J. L., Hao, Y., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307819101 · Cited by 459 · cited 1×
“The first GTKO pigs did not become available until 2003 (Phelps et al. 2003; Kolber-Simonds et al. 2004), and my colleagues and I at the TBRCwere the first to test the transplantation of organs from these pigs in immunosuppressed baboons (Kuwaki et al. 2005; Tseng et al. 2005a; Yamada et al. 2005;…”
BackgroundEstrada, J. L., Martens, G., Li, P., Adams, A., Newell, K. A., Ford, M. L., Butler, J. R., Sidner, R., Tector, M., & Tector, J. (2015) · Xenotransplantation · doi:10.1111/xen.12161 · Cited by 417 · cited 2×
“Tector and his colleagues have demonstrated that∼25%of humans do not appear to have natural antibodies to any other targets on these “triple-knockout” pig cells (Estrada et al. 2015).”
BackgroundORIOL, R., YE, Y., KOREN, E., & COOPER, D. K. C. (1993) · Transplantation · doi:10.1097/00007890-199312000-00031 · Cited by 416 · cited 2×
“In vitro studies by our group showed this to be the case (Table 2) (Koren et al. 1993; Oriol et al. 1993; Kujundzic et al. 1994; Neethling et al. 1994; Oriol et al. 1994; Neethling et al. 1996; Neethling and Cooper 1999; Oriol et al. 1999).”
BackgroundSelf-citationThall, A. D., Malý, P., & Lowe, J. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21437 · Cited by 401 · cited 3×
“It was soon possible to produce a GTKOmouse (Thall et al. 1995; Tearle et al. 1996), but knockout of the GT gene in pigs only became possible after the development of the technology that produced the world’s first cloned mammal, the sheep known as “Dolly” (Campbell et al. 1996) and, subsequently,…”
BackgroundCooper, D. K. C., Good, A. H., Koren, E., Oriol, R., Malcolm, A. J., Ippolito, R. M., Neethling, F. A., Ye, Y., Romano, E., & Zuhdi, N. (1993) · Transplant Immunology · doi:10.1016/0966-3274(93)90047-c · Cited by 375 · cited 4×
“Based on this approach, I was greatly excited when one of the Chembiomed scientists, Heather Good, informed me that a major target for human anti-pig antibodies was the Gal epitope (galactose-α (1,3)-galactose) (Cooper 1992b, 1994; Good et al. 1992; Cooper et al. 1993a; ; Kobayashi and Cooper 1999).”
BackgroundSelf-citationTHE ??-1,3-GALACTOSYLTRANSFERASE KNOCKOUT MOUSE: Implications for Xenotransplantation1
Tearle, R. G., Tange, M. J., Zannettino, Z. L., Katerelos, M., Shinkel, T. A., Van Denderen, B. J. W., Lonie, A. J., Lyons, I., Nottle, M. B., Cox, T., et al. (1996) · Transplantation · doi:10.1097/00007890-199601150-00004 · Cited by 306 · cited 1×
“It was soon possible to produce a GTKOmouse (Thall et al. 1995; Tearle et al. 1996), but knockout of the GT gene in pigs only became possible after the development of the technology that produced the world’s first cloned mammal, the sheep known as “Dolly” (Campbell et al. 1996) and, subsequently,…”
BackgroundLutz, A. J., Li, P., Estrada, J. L., Sidner, R. A., Chihara, R. K., Downey, S. M., Burlak, C., Wang, Z., Reyes, L. M., Ivary, B., et al. (2013) · Xenotransplantation · doi:10.1111/xen.12019 · Cited by 294 · cited 1×
“The relevance of anti-NeuGc antibodies has been tested in vitro using human serum and pig cells, but it has only been relatively recently that pigs in which expression of both Gal and NeuGc has been deleted have become available (Figure 3) (Lutz et al. 2013; Lee et al. 2016a).”
BackgroundOligosaccharides and Discordant Xenotransplantation
Cooper, D. K. C., Koren, E., & Oriol, R. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00871.x · Cited by 254 · cited 1×
“The role of Gal in xenotransplantation Based on this approach, I was greatly excited when one of the Chembiomed scientists, Heather Good, informed me that a major target for human anti-pig antibodies was the Gal epitope (galactose-α(1,3)-galactose) (Cooper 1992b; Good et al. 1992; Cooper et al. 1993a; Cooper et al. 19…”
BackgroundSelf-citationGalili, U., Buehler, J., Shohet, S. B., & Macher, B. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.3.693 · Cited by 229 · cited 1×
“…by the observation that there are similarities between the structure of Gal and those of the ABO blood group antigens (Stussi et al. 2006) (Figure 1), particularly between Gal and blood group B (Galili et al. 1987; Galili 2006), suggesting that the human immune response would be similar to both.”
BackgroundThe role of genetically engineered pigs in xenotransplantation research
Cooper, D. K., Ekser, B., Ramsoondar, J., Phelps, C., & Ayares, D. (2016) · The Journal of Pathology · doi:10.1002/path.4635 · Cited by 219
Self-citationEffects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon.
Cooper, D. K., Human, P. A., Lexer, G. W., Rose, A. G., Rees, J., Keraan, M., & Toit, E. D. (1988) · PubMed · Cited by 215
Self-citationXu, Y., Lorf, T., Sablinski, T., Gianello, P., Bailin, M., Monroy, R., Kozlowski, T., Awwad, M., Cooper, D. K. C., & Sachs, D. H. (1998) · Transplantation · doi:10.1097/00007890-199801270-00005 · Cited by 195 · cited 1×
“…of anti-Gal antibodies (using immunoaffinity columns of synthetic Gal) in baboons, some of whom subsequently underwent organ or bone marrow transplantation (Kozlowski et al. 1998a, b; Lambrigts et al. 1998; Xu et al. 1998; Watts et al. 2000; Buhler et al. 2001; Kuwaki et al. 2004).”
BackgroundSelf-citationTseng, Y.-L., Kuwaki, K., Dor, F. J. M. F., Shimizu, A., Houser, S., Hisashi, Y., Yamada, K., Robson, S. C., Awwad, M., Schuurman, H.-J., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000181397.41143.fa · Cited by 194 · cited 2×
“In these studies, for a short period of time, we were able to consult with Robert Sackstein who, although then new to the field of glycobiology, was invaluable to us for his expertise and advice in bone marrow transplantation as a means to induce immune tolerance (Tseng et al. 2004, 2005b).”
BackgroundSelf-citationCooper, D. K. C., Koren, E., & Oriol, R. (1993) · The Lancet · doi:10.1016/0140-6736(93)91791-j · Cited by 185 · cited 4×
“At the time of the Minneapolis meeting, in discussion with my two invaluable colleagues, Eugene Koren and Rafael Oriol (an immunogeneticist from Paris with a special interest in ABO blood group antigens), we determined that, when the technology was available, it should be possible to knockout the gene for the enzyme t…”
BackgroundSelf-citationB??hler, L., Basker, M., Alwayn, I. P. J., Goepfert, C., Kitamura, H., Kawai, T., Gojo, S., Kozlowski, T., Ierino, F. L., Awwad, M., et al. (2000) · Transplantation · doi:10.1097/00007890-200011150-00010 · Cited by 183 · cited 4×
“14 developed that ultimately led to graft failure (Buhler et al. 2000; Houser et al. 2004).”
BackgroundSelf-citationDisordered regulation of coagulation and platelet activation in xenotransplantation
Robson, S. C., Cooper, D. K. C., & D'Apice, A. J. F. (2000) · Xenotransplantation · doi:10.1034/j.1399-3089.2000.00067.x · Cited by 173 · cited 1×
“These observations (and important previous studies by others (reviewed in Robson et al. 2000), generated investigation into the nature of the coagulation/anticoagulation discrepancies between pigs and primates and eventually to the genetic modification of GTKO pigs to express human…”
Self-citationKozlowski, T., Shimizu, A., Lambrigts, D., Yamada, K., Fuchimoto, Y., Glaser, R., Monroy, R., Xu, Y., Awwad, M., Colvin, R. B., et al. (1999) · Transplantation · doi:10.1097/00007890-199901150-00004 · Cited by 168 · cited 2×
“If the thrombotic microangiopathy became advanced (by aggregation of platelets and fibrin in the graft), a consumptive coagulopathy could develop that could be life-threatening to the recipient baboon (Ierino et al. 1998; Kozlowski et al. 1999; Buhler et al. 2000; Ezzelarab et al. 2009).”
BackgroundSelf-citationPotential impact of the non‐human sialic acid N‐glycolylneuraminic acid on transplant rejection risk
Padler‐Karavani, V., & Varki, A. (2011) · Xenotransplantation · doi:10.1111/j.1399-3089.2011.00622.x · Cited by 162 · cited 1×
“Just as I had read all of Uri Galili’s papers on Gal, I now followed the studies by Ajit Varki’s group on NeuGc (reviewed in Padler-Karavani and Varki 2011).”
BackgroundByrne, G. W., Du, Z., Stalboerger, P., Kogelberg, H., & McGregor, C. G. A. (2014) · Xenotransplantation · doi:10.1111/xen.12124 · Cited by 156 · cited 1×
“…investigation (Cooper 1998; Ezzelarab et al. 2005; Yeh et al. 2010), only one further oligosaccharide antigen has been definitively identified as being of relevance to xenotransplantation, which is a product of the gene, β(1,4)N-acetylgalactosaminyltransferase (β4GalNT2) (Byrne et al. 2014).”
BackgroundShimizu, A., Hisashi, Y., Kuwaki, K., Tseng, Y., Dor, F. J. M. F., Houser, S. L., Robson, S. C., Schuurman, H., Cooper, D. K. C., Sachs, D. H., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070672 · Cited by 146
Self-citationEzzelarab, M., Garcia, B., Azimzadeh, A., Sun, H., Lin, C. C., Hara, H., Kelishadi, S., Zhang, T., Lin, Y. J., Tai, H.-C., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e318199c34f · Cited by 143 · cited 2×
“If the thrombotic microangiopathy became advanced (by aggregation of platelets and fibrin in the graft), a consumptive coagulopathy could develop that could be life-threatening to the recipient baboon (Ierino et al. 1998; Kozlowski et al. 1999; Buhler et al. 2000; Ezzelarab et al. 2009).”
BackgroundSelf-citationIN VIVO IMMUNOADSORPTION OF ANTIPIG ANTIBODIES IN BABOONS USING A SPECIFIC GAL??1-3GAL COLUMN
Taniguchi, S., Neethling, F. A., Korchagina, E., Bovin, N. V., Ye, Y., Kobayashi, T., Niekrasz, M., Li, S., Koren, E., Oriol, R., et al. (1996) · Transplantation · doi:10.1097/00007890-199611270-00001 · Cited by 140 · cited 2×
“We even briefly explored the possibility of using organs from non-mammal species, e.g., ratites (ostriches, emus) that do not express Gal (Taniguchi et al. 1996a).”
BackgroundSelf-citationXenoantigens and xenoantibodies
Cooper, D. K. C. (1998) · Xenotransplantation · doi:10.1111/j.1399-3089.1998.tb00003.x · Cited by 139 · cited 1×
“Despite considerable investigation (Cooper 1998; Ezzelarab et al. 2005; Yeh et al. 2010), only one further oligosaccharide antigen has been definitively identified as being of relevance to xenotransplantation, which is a product of the gene, β(1,4)N-acetylgalactosaminyltransferase (β4GalNT2) (Byrne…”
BackgroundSelf-citationKoenderman, L., Buurman, W. A., & Daha, M. R. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.10.010 · Cited by 138
Simon, P. M., Neethling, F. A., Taniguchi, S., Goode, P. L., Zopf, D., Hancock, W. W., & Cooper, D. K. C. (1998) · Transplantation · doi:10.1097/00007890-199802150-00009 · Cited by 137 · cited 2×
“1996b), and indeed found that antibody-mediated rejection of a pig heart was delayed (Simon et al. 1998; Romano et al. 1999).”
BackgroundSelf-citationIerino, F. L., Kozlowski, T., Siegel, J. B., Shimizu, A., Colvin, R. B., Banerjee, P. T., Cooper, D. K. C., Cosimi, A. B., Bach, F. H., Sachs, D. H., et al. (1998) · Transplantation · doi:10.1097/00007890-199812150-00006 · Cited by 137 · cited 1×
“If the thrombotic microangiopathy became advanced (by aggregation of platelets and fibrin in the graft), a consumptive coagulopathy could develop that could be life-threatening to the recipient baboon (Ierino et al. 1998; Kozlowski et al. 1999; Buhler et al. 2000; Ezzelarab et al. 2009).”
BackgroundSelf-citationHouser, S. L., Kuwaki, K., Knosalla, C., Dor, F. J. M. F., Gollackner, B., Cheng, J. J., Shimizu, A., Schuurman, H., & Cooper, D. K. C. (2004) · Xenotransplantation · doi:10.1111/j.1399-3089.2004.00155.x · Cited by 135 · cited 2×
“14 developed that ultimately led to graft failure (Buhler et al. 2000; Houser et al. 2004).”
BackgroundSelf-citationXenotransplantation-The Future of Corneal Transplantation?
Hara, H., & Cooper, D. K. C. (2011) · Cornea · doi:10.1097/ico.0b013e3181f237ef · Cited by 128
Self-citationYE, Y., NEETHLING, F. A., NIEKRASZ, M., KOREN, E., RICHARDS, S. V., MARTIN, M., KOSANKE, S., ORIOL, R., & COOPER, D. K. C. (1994) · Transplantation · doi:10.1097/00007890-199408000-00014 · Cited by 128 · cited 3×
“…and satisfaction, the continuous i.v. infusion of the A or B oligosaccharides into baboons allowed AB-incompatible heart grafts to function until cellular rejection (unrelated toAB-incompatibility) developed, as it would in anAB-compatible heart transplant (Cooper et al. 1993c; Ye et al. 1994b).”
BackgroundSelf-citationDepletion of anti‐Galα1–3Gal antibody in baboons by specific α‐Gal immunoaffinity columns
Kozłowski, T., Ierino, F. L., Lambrigts, D., Foley, A., Andrews, D., Awwad, M., Monroy, R. L., Cosimi, A. B., Cooper, D. K. C., & Sachs, D. H. (1998) · Xenotransplantation · doi:10.1111/j.1399-3089.1998.tb00018.x · Cited by 117 · cited 1×
“…of anti-Gal antibodies (using immunoaffinity columns of synthetic Gal) in baboons, some of whom subsequently underwent organ or bone marrow transplantation (Kozlowski et al. 1998a, b; Lambrigts et al. 1998; Xu et al. 1998; Watts et al. 2000; Buhler et al. 2001; Kuwaki et al. 2004).”
BackgroundSelf-citationCarbohydrates in xenotransplantation
Ezzelarab, M., Ayares, D., & Cooper, D. K. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01344.x · Cited by 117 · cited 2×
“Despite considerable investigation (Cooper 1998; Ezzelarab et al. 2005; Yeh et al. 2010), only one further oligosaccharide antigen has been definitively identified as being of relevance to xenotransplantation, which is a product of the gene, β(1,4)N-acetylgalactosaminyltransferase (β4GalNT2) (Byrne…”
BackgroundSelf-citationBouhours, D., Pourcel, C., & Bouhours, J.-F. (1996) · Glycoconjugate Journal · doi:10.1007/bf01053190 · Cited by 113 · cited 1×
“Reproduced with permission from Neethling et al. (1996). expressed N-glycolylneuraminic acid (NeuGc) on the vascular endothelium (Bouhours et al. 1996).”
BackgroundBühler, L. H., Yamada, K., Kitamura, H., Alwayn, I. P. J., Basker, M., Appel, J. Z., Colvin, R. B., White‐Scharf, M. E., Sachs, D. H., Robson, S. C., et al. (2001) · Transplantation · doi:10.1097/00007890-200112150-00007 · Cited by 112 · cited 2×
“…of anti-Gal antibodies (using immunoaffinity columns of synthetic Gal) in baboons, some of whom subsequently underwent organ or bone marrow transplantation (Kozlowski et al. 1998a, b; Lambrigts et al. 1998; Xu et al. 1998; Watts et al. 2000; Buhler et al. 2001; Kuwaki et al. 2004).”
BackgroundSelf-citationNeethling, F. A., Koren, E., YE, Y., RICHARDS, S. V., Kujundžić, M., Oriol, R., & Cooper, D. K. C. (1994) · Transplantation · doi:10.1097/00007890-199403270-00032 · Cited by 107 · cited 2×
“In vitro studies by our group showed this to be the case (Table 2) (Koren et al. 1993; Oriol et al. 1993; Kujundzic et al. 1994; Neethling et al. 1994; Oriol et al. 1994; Neethling et al. 1996; Neethling and Cooper 1999; Oriol et al. 1999).”
BackgroundSelf-citationHyperacute rejection in a discordant (pig to baboon) cardiac xenograft model.
Lexer, G. W., Cooper, D. K., Rose, A. G., Wicomb, W. N., Rees, J., Keraan, M., & Toit, E. D. (1986) · PubMed · Cited by 106
Self-citationCorneal blindness and xenotransplantation
Lamm, V., Hara, H., Mammen, A., Dhaliwal, D., & Cooper, D. K. C. (2014) · Xenotransplantation · doi:10.1111/xen.12082 · Cited by 105 · cited 1×
“Genetically engineered pigs could also be a source of corneas for the hundreds of thousands of patients worldwide with corneal blindness (Hara and Cooper 2011; Lamm et al. 2014; Lee et al. 2016b).”
BackgroundSelf-citationAzimzadeh, A. M., Kelishadi, S., Ezzelarab, M. B., Singh, A. K., Stoddard, T. A., Iwase, H., Zhang, T., Burdorf, L., Sievert, E. P., Avon, C., et al. (2015) · Xenotransplantation · doi:10.1111/xen.12176 · Cited by 104 · cited 1×
“Subsequently, GTKO pigs were genetically engineered to express a human complement-regulatory protein, which has further enhanced graft survival (Azimzadeh et al. 2015).”
BackgroundSelf-citationCooper, D. K. C., YE, Y., Niekrasz, M., Kehoe, M., MARTIN, M., Neethling, F. A., Kosanke, S. D., DeBault, L. E., Worsley, G., Zuhdi, N., et al. (1993) · Transplantation · doi:10.1097/00007890-199310000-00001 · Cited by 103 · cited 3×
“Based on this approach, I was greatly excited when one of the Chembiomed scientists, Heather Good, informed me that a major target for human anti-pig antibodies was the Gal epitope (galactose-α (1,3)-galactose) (Cooper 1992b, 1994; Good et al. 1992; Cooper et al. 1993a; ; Kobayashi and Cooper 1999).”
BackgroundSelf-citationHara, H., Ezzelarab, M. B., Rood, P. P. M., Lin, Y. J., Busch, J., Ibrahim, Z., Zhu, X., Ball, S. F., Ayares, D., Zeevi, A., et al. (2006) · Xenotransplantation · doi:10.1111/j.1399-3089.2006.00319.x · Cited by 102 · cited 2×
“…in 2004 and, around that time and subsequently, several studies were carried out on GTKO pigs (Dor et al. 2004b; Knosalla et al. 2004; Ekser et al. 2012; Fang et al. 2012) and their cells were used for in vitro assays (Ezzelarab et al. 2006; Hara et al. 2006; Rood et al. 2006;Wong et al. 2006).”
MethodSelf-citationHisashi, Y., Yamada, K., Kuwaki, K., Tseng, Y.-L., Dor, F. J. M. F., Houser, S. L., Robson, S. C., Schuurman, H.-J., Cooper, D. K. C., Sachs, D. H., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02444.x · Cited by 97 · cited 2×
“2004), and my colleagues and I at the TBRC were the first to test the transplantation of organs from these pigs in immunosuppressed baboons (Kuwaki et al. 2005; Tseng et al. 2005a; Yamada et al. 2005; Hisashi et al. 2008; Shimizu et al. 2008).”
BackgroundSelf-citationCooper, D. K. C. (1992) · Clinical Transplantation · doi:10.1111/j.1399-0012.1992.tb00614.x · Cited by 94 · cited 1×
“Despite considerable investigation (Cooper 1998; Ezzelarab et al. 2005; Yeh et al. 2010), only one further oligosaccharide antigen has been definitively identified as being of relevance to xenotransplantation, which is a product of the gene, β(1,4)N-acetylgalactosaminyltransferase (β4GalNT2) (Byrne…”
BackgroundSelf-citationBioprosthetic heart valves of the future
Manji, R. A., Ekser, B., Menkis, A. H., & Cooper, D. K. C. (2014) · Xenotransplantation · doi:10.1111/xen.12080 · Cited by 91 · cited 1×
“Bioprosthetic heart valves from pigs (that are implanted in their thousands each year into patients with cardiac valve disease) will almost certainly function for longer periods if obtained fromGTKO/CMAHKO/β4GalNT2KO pigs (Cooper 2009a; Manji et al. 2014).”
BackgroundSelf-citationDor, F. J. M. F., Tseng, Y., Cheng, J. J., Moran, K., Sanderson, T. M., Lancos, C. J., Shimizu, A., Yamada, K., Awwad, M., Sachs, D. H., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000130487.68051.eb · Cited by 87 · cited 2×
“I moved to the University of Pittsburgh in 2004 and, around that time and subsequently, several studies were carried out on GTKO pigs (Dor et al. 2004b; Knosalla et al. 2004; Ekser et al. 2012; Fang et al. 2012) and their cells were used for in vitro assays (Ezzelarab et al. 2006; Hara et al. 2006;…”
BackgroundMethodSelf-citationSpringer, S. A., Diaz, S. L., & Gagneux, P. (2014) · Immunogenetics · doi:10.1007/s00251-014-0795-0 · Cited by 87 · cited 2×
“The effect of cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) gene-knockout has not yet been explored in vivo because it was thought there was no relevant animal model, but it has been recently demonstrated that NeuGc is not expressed in New World monkeys (Springer et al. 2014), which therefore can d…”
BackgroundClinical survey of heart transplantation between ABO blood group-incompatible recipients and donors.
Cooper, D. K. (1990) · PubMed · Cited by 84
Self-citationCooper, D. K. C. (1992) · PubMed · Cited by 84
Self-citationKozłowski, T., Monroy, R. L., Xu, Y., Gläser, R., Awwad, M., Cooper, D. K. C., & Sachs, D. H. (1998) · Transplantation · doi:10.1097/00007890-199807270-00006 · Cited by 82 · cited 1×
“…of anti-Gal antibodies (using immunoaffinity columns of synthetic Gal) in baboons, some of whom subsequently underwent organ or bone marrow transplantation (Kozlowski et al. 1998a, b; Lambrigts et al. 1998; Xu et al. 1998; Watts et al. 2000; Buhler et al. 2001; Kuwaki et al. 2004).”
BackgroundSelf-citationWong, B. S., Yamada, K., Okumi, M., Weiner, J. I., Malley, P. E. O., Tseng, Y., Dor, F. J. M. F., Cooper, D. K. C., Saidman, S. L., Griesemer, A., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000228907.12073.0b · Cited by 80 · cited 1×
“…in 2004 and, around that time and subsequently, several studies were carried out on GTKO pigs (Dor et al. 2004b; Knosalla et al. 2004; Ekser et al. 2012; Fang et al. 2012) and their cells were used for in vitro assays (Ezzelarab et al. 2006; Hara et al. 2006; Rood et al. 2006;Wong et al. 2006).”
MethodSelf-citationAnti-Gal, α-Gal Epitopes, and Xenotransplantation
Kobayashi, T., & Cooper, D. K. C. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4771-6_10 · Cited by 77
Self-citationRieben, R., von Allmen, E., Korchagina, E., Nydegger, U. E., Neethling, F. A., Kujundžić, M., Koren, E., Bovin, N. V., & Cooper, D. K. C. (1995) · Xenotransplantation · doi:10.1111/j.1399-3089.1995.tb00072.x · Cited by 74 · cited 1×
“…sufficient specific synthetic Gal from several different sources (including Nicolai Bovin in Moscow) to test our hypothesis in vivo in baboons (Rieben et al. 1995; Cooper et al. 1996a; Taniguchi et al. 1996b), and indeed found that antibody-mediated rejection of a pig heart was delayed (Simon…”
BackgroundSelf-citationYeh, P., Ezzelarab, M., Bovin, N., Hara, H., Long, C., Tomiyama, K., Sun, F., Ayares, D., Awwad, M., & Cooper, D. K. C. (2010) · Xenotransplantation · doi:10.1111/j.1399-3089.2010.00579.x · Cited by 73 · cited 2×
“Despite considerable investigation (Cooper 1998; Ezzelarab et al. 2005; Yeh et al. 2010), only one further oligosaccharide antigen has been definitively identified as being of relevance to xenotransplantation, which is a product of the gene, β(1,4)Nacetylgalactosaminyltransferase (β4GalNT2) (Byrne et al.”
BackgroundSelf-citationAntibodies directed to pig non‐Gal antigens in naïve and sensitized baboons
Ezzelarab, M., Hara, H., Busch, J., Rood, P. P. M., Zhu, X., Ibrahim, Z., Ball, S., Ayares, D., Awwad, M., & Cooper, D. K. C. (2006) · Xenotransplantation · doi:10.1111/j.1399-3089.2006.00320.x · Cited by 70 · cited 2×
“…in 2004 and, around that time and subsequently, several studies were carried out on GTKO pigs (Dor et al. 2004b; Knosalla et al. 2004; Ekser et al. 2012; Fang et al. 2012) and their cells were used for in vitro assays (Ezzelarab et al. 2006; Hara et al. 2006; Rood et al. 2006;Wong et al. 2006).”
MethodSelf-citationMinanov, O. P., Itescu, S., Neethling, F. A., Morgenthau, A. S., Kwiatkowski, P. A., Cooper, D. K. C., & Michler, R. E. (1997) · Transplantation · doi:10.1097/00007890-199701270-00002 · Cited by 64
Self-citationWang, Z., Burlak, C., Estrada, J. L., Li, P., Tector, M. F., & Tector, A. J. (2014) · Xenotransplantation · doi:10.1111/xen.12106 · Cited by 64 · cited 1×
“The absence of Gal and NeuGc expression on erythrocytes takes us one step closer to being able to use pig red blood cells for transfusion in humans (Rouhani et al. 2004; Cooper et al. 2010; Wang et al. 2014).”
BackgroundLambrigts, D., Calster, P. V., Xu, Y., Awwad, M., Neethling, F. A., Kozłowski, T., Foley, A., Watts, A. G., Chae, S. J., Fishman, J. A., et al. (1998) · Xenotransplantation · doi:10.1111/j.1399-3089.1998.tb00038.x · Cited by 63 · cited 1×
“…of anti-Gal antibodies (using immunoaffinity columns of synthetic Gal) in baboons, some of whom subsequently underwent organ or bone marrow transplantation (Kozlowski et al. 1998a, b; Lambrigts et al. 1998; Xu et al. 1998; Watts et al. 2000; Buhler et al. 2001; Kuwaki et al. 2004).”
BackgroundSelf-citationXenotransplantation and ABO incompatible transplantation: The similarities they share
Galili, U. (2006) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2006.05.007 · Cited by 63 · cited 2×
“…by the observation that there are similarities between the structure of Gal and those of the ABO blood group antigens (Stussi et al. 2006) (Figure 1), particularly between Gal and blood group B (Galili et al. 1987; Galili 2006), suggesting that the human immune response would be similar to both.”
BackgroundOriol, R., Barthod, F., Bergemer, A. M., Ye, Y., Koren, E., & Cooper, D. K. C. (1994) · Transplant International · doi:10.1007/bf00346034 · Cited by 62 · cited 2×
“In vitro studies by our group showed this to be the case (Table 2) (Koren et al. 1993; Oriol et al. 1993; Kujundzic et al. 1994; Neethling et al. 1994; Oriol et al. 1994; Neethling et al. 1996; Neethling and Cooper 1999; Oriol et al. 1999).”
BackgroundSelf-citationGalα1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus
Dor, F. J. M. F., Cheng, J. J., Alt, A., Cooper, D. K. C., & Schuurman, H. (2003) · Xenotransplantation · doi:10.1111/j.1399-3089.2004.00078.x · Cited by 62 · cited 3×
“I moved to the University of Pittsburgh in 2004 and, around that time and subsequently, several studies were carried out on GTKO pigs (Dor et al. 2004b; Knosalla et al. 2004; Ekser et al. 2012; Fang et al. 2012) and their cells were used for in vitro assays (Ezzelarab et al. 2006; Hara et al. 2006;…”
BackgroundMethodSelf-citationAnti‐Galα1‐3Gal IgM and IgG antibody levels in sera of humans and old world non‐human primates
Teranishi, K., Manez, R., Awwad, M., & Cooper, D. K. C. (2002) · Xenotransplantation · doi:10.1034/j.1399-3089.2002.1o058.x · Cited by 60 · cited 3×
“2004a), and anti-Gal antibody in various species under differing circumstances (Gojo et al. 2000; Teranishi et al. 2002b).”
BackgroundSelf-citationKujundžić, M., Koren, E., Neethling, F. A., Mitotic, F., Koscec, M., Kujundzic, T., Martin, M., & Cooper, D. K. C. (1994) · Xenotransplantation · doi:10.1111/j.1399-3089.1994.tb00050.x · Cited by 58 · cited 1×
“In vitro studies by our group showed this to be the case (Table II) (Koren et al. 1993; Oriol et al. 1993, 1994, 1999; Kujundzic et al. 1994; Neethling et al. 1994, 1996; Neethling and Cooper 1999).”
BackgroundSelf-citationRood, P. P. M., Tai, H., Hara, H., Long, C. E., Ezzelarab, M. B., Lin, Y. J., van der Windt, D. J., Busch, J., Ayares, D., IJzermans, J. N. M., et al. (2007) · Transplant International · doi:10.1111/j.1432-2277.2007.00546.x · Cited by 57 · cited 1×
“…do not make antipig (or anti-Gal) antibodies (or anti-A or B antibodies) for the first 3 months or so of life (Neethling et al. 1995; Minanov et al. 1997; Rood et al. 2007; Dons et al. 2012), at which time they begin to develop these antibodies, presumably after colonization of the GI tracts.”
BackgroundSelf-citationThe effect of Gal expression on pig cells on the human T‐cell xenoresponse
Wilhite, T., Ezzelarab, C., Hara, H., Long, C., Ayares, D., Cooper, D. K. C., & Ezzelarab, M. (2012) · Xenotransplantation · doi:10.1111/j.1399-3089.2011.00691.x · Cited by 55 · cited 2×
“…the absence of Gal expression on pig tissues was associated with a reduction in the primate cellular response (as well as the expected humoral response) to the graft, which has proved beneficial in overcoming the immunological barriers to successful xenotransplantation (Wilhite et al. 2012).”
BackgroundSelf-citationEkser, B., Bianchi, J., Ball, S., Iwase, H., Walters, A., Ezzelarab, M., Veroux, M., Gridelli, B., Wagner, R., Ayares, D., et al. (2012) · Xenotransplantation · doi:10.1111/xen.12007 · Cited by 52 · cited 1×
“…of Pittsburgh in 2004 and, around that time and subsequently, several studies were carried out on GTKO pigs (Dor et al. 2004b; Knosalla et al. 2004; Ekser et al. 2012; Fang et al. 2012) and their cells were used for in vitro assays (Ezzelarab et al. 2006; Hara et al. 2006; Rood et al. 2006;Wong et…”
MethodSelf-citationWatts, A., Foley, A., Awwad, M., Treter, S., Oravec, G., Bühler, L. H., Alwayn, I. P. J., Kozłowski, T., Lambrigts, D., Gojo, S., et al. (2000) · Xenotransplantation · doi:10.1034/j.1399-3089.2000.00068.x · Cited by 52 · cited 2×
“…of anti-Gal antibodies (using immunoaffinity columns of synthetic Gal) in baboons, some of whom subsequently underwent organ or bone marrow transplantation (Kozlowski et al. 1998a, b; Lambrigts et al. 1998; Xu et al. 1998; Watts et al. 2000; Buhler et al. 2001; Kuwaki et al. 2004).”
BackgroundSelf-citationPorcine Hematopoietic Progenitor Cell Transplantation in Nonhuman Primates: A Review of Progress
Tseng, Y.-L., Sachs, D. H., & Cooper, D. K. C. (2004) · Transplantation · doi:10.1097/01.tp.0000146504.73727.13 · Cited by 51 · cited 3×
“In these studies, for a short period of time, we were able to consult with Robert Sackstein who, although then new to the field of glycobiology, was invaluable to us for his expertise and advice in bone marrow transplantation as a means to induce immune tolerance (Tseng et al. 2004, 2005b).”
BackgroundSelf-citationBone marrow transplantation from α1,3‐galactosyltransferase gene‐knockout pigs in baboons
Tseng, Y., Dor, F. J. M. F., Kuwaki, K., Ryan, D., Wood, J., Denaro, M., Giovino, M. A., Yamada, K., Hawley, R., Patience, C., et al. (2004) · Xenotransplantation · doi:10.1111/j.1399-3089.2004.00151.x · Cited by 47 · cited 1×
“In these studies, for a short period of time, we were able to consult with Robert Sackstein who, although then new to the field of glycobiology, was invaluable to us for his expertise and advice in bone marrow transplantation as a means to induce immune tolerance (Tseng et al. 2004, 2005b).”
BackgroundSelf-citationOriol, R., Candelier, J., Taniguchi, S., Balanzino, L. E., Peters, L., Niekrasz, M., Hammer, C., & Cooper, D. K. C. (1999) · Xenotransplantation · doi:10.1034/j.1399-3089.1999.00008.x · Cited by 47 · cited 2×
“In vitro studies by our group showed this to be the case (Table 2) (Koren et al. 1993; Oriol et al. 1993; Kujundzic et al. 1994; Neethling et al. 1994; Oriol et al. 1994; Neethling et al. 1996; Neethling and Cooper 1999; Oriol et al. 1999).”
BackgroundSelf-citationInitial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs
Lee, W., Hara, H., Ezzelarab, M. B., Iwase, H., Bottino, R., Long, C., Ramsoondar, J., Ayares, D., & Cooper, D. K. C. (2016) · Xenotransplantation · doi:10.1111/xen.12229 · Cited by 47 · cited 2×
“The relevance of anti-NeuGc antibodies has been tested in vitro using human serum and pig cells, but it has only been relatively recently that pigs in which expression of both Gal and NeuGc has been deleted have become available (Figure 3) (Lutz et al. 2013; Lee et al. 2016a).”
BackgroundSelf-citationRomano, E. L., Neethling, F. A., NILSSON, K. G. I., Kosanke, S. D., Shimizu, A., Magnusson, S., Svensson, L., Samuelsson, B. E., & Cooper, D. K. C. (1999) · Xenotransplantation · doi:10.1034/j.1399-3089.1999.00005.x · Cited by 46 · cited 2×
“1996b), and indeed found that antibody-mediated rejection of a pig heart was delayed (Simon et al. 1998; Romano et al. 1999).”
BackgroundSelf-citationRood, P. P. M., Hara, H., Busch, J., Ezzelarab, M. B., Zhu, X., Ball, S. F., Ayares, D., Awwad, M., & Cooper, D. K. C. (2006) · Transplant International · doi:10.1111/j.1432-2277.2005.00252.x · Cited by 46 · cited 2×
“…in 2004 and, around that time and subsequently, several studies were carried out on GTKO pigs (Dor et al. 2004b; Knosalla et al. 2004; Ekser et al. 2012; Fang et al. 2012) and their cells were used for in vitro assays (Ezzelarab et al. 2006; Hara et al. 2006; Rood et al. 2006;Wong et al. 2006).”
MethodSelf-citationRecent advances in understanding xenotransplantation: implications for the clinic
Cooper, D. K. C., & Bottino, R. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1083861 · Cited by 45 · cited 3×
“For example, the transplantation of pig pancreatic islets could provide a cure for the millions of patients worldwide with diabetes (Cooper and Bottino 2015).”
BackgroundSelf-citationNeethling, F. A., Joziasse, D. H., Bovin, N. V., Cooper, D. K. C., & Oriol, R. (1996) · Transplant International · doi:10.1007/bf00336385 · Cited by 44
Self-citationAnti‐gal antibodies in α1,3‐galactosyltransferase gene‐knockout pigs
Fang, J., Walters, A., Hara, H., Long, C., Yeh, P., Ayares, D., Cooper, D. K. C., & Bianchi, J. (2012) · Xenotransplantation · doi:10.1111/j.1399-3089.2012.00710.x · Cited by 43 · cited 1×
“…in 2004 and, around that time and subsequently, several studies were carried out on GTKO pigs (Dor et al. 2004b; Knosalla et al. 2004; Ekser et al. 2012; Fang et al. 2012) and their cells were used for in vitro assays (Ezzelarab et al. 2006; Hara et al. 2006; Rood et al. 2006;Wong et al. 2006).”
MethodSelf-citationPig xenogeneic antigen modification with green coffee bean α‐galactosidase
Luo, Y., Wen, J., Luo, C., Cummings, R. D., & Cooper, D. K. C. (1999) · Xenotransplantation · doi:10.1034/j.1399-3089.1999.00035.x · Cited by 43 · cited 2×
“In Oklahoma City at that time, we were fortunate to have the advice and collaboration of the well-known glycobiologist, Richard Cummings, with whom we explored other options for obtaining Gal sugars and of reducing antibody binding (Li et al. 1995; Li et al. 1996; Luo et al. 1999).”
BackgroundSelf-citationCooper, D. K. C., Human, P., Rose, A. G., Rees, J., Keraan, M., Reichart, B., du Toit, E. D., & Oriol, R. (1989) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)34585-4 · Cited by 43
Self-citationBinding and specificity of major immunoglobulin classes of preformed human anti-pig heart antibodies
Koren, E., Neethling, F. A., Richards, S., Koscec, M., Ye, Y., Zuhdi, N., & Cooper, D. K. C. (1993) · Transplant International · doi:10.1007/bf00335975 · Cited by 40 · cited 2×
“In vitro studies by our group showed this to be the case (Table 2) (Koren et al. 1993; Oriol et al. 1993; Kujundzic et al. 1994; Neethling et al. 1994; Oriol et al. 1994; Neethling et al. 1996; Neethling and Cooper 1999; Oriol et al. 1999).”
BackgroundSelf-citationTeranishi, K., Gollackner, B., Bühler, L. H., Knosalla, C., Correa, L., Down, J. D., White‐Scharf, M. E., Sachs, D. H., Awwad, M., & Cooper, D. K. C. (2002) · Transplantation · doi:10.1097/00007890-200201150-00024 · Cited by 39 · cited 1×
“We also intravenously infused Gal conjugates (Teranishi et al. 2002a; Gollackner et al. 2003; Teranishi et al. 2003; Kuwaki et al. 2004).”
Self-citationEvolution of α1,3Galactosyltransferase and of the α-Gal Epitope
Galili, U. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4771-6_1 · Cited by 37 · cited 1×
“I then avidly read all I could about Gal antigens and anti-Gal antibodies, largely from thewritings of Galili and his colleagues (Galili 1999).”
BackgroundABO‐incompatible allotransplantation as a basis for clinical xenotransplantation
Stüssi, G., West, L. J., Cooper, D. K. C., & Seebach, J. D. (2006) · Xenotransplantation · doi:10.1111/j.1399-3089.2006.00324.x · Cited by 32 · cited 2×
“I was encouraged by the observation that there are similarities between the structure of Gal and those of the ABO blood group antigens (Stussi et al. 2006) (Figure 1), particularly between Gal and blood group B (Galili et al. 1987; Galili 2006), suggesting that the human immune response would be…”
BackgroundSelf-citationSERUM CYTOTOXICITY TO PIG CELLS AND ANTI-??GAL ANTIBODY LEVEL AND SPECIFICITY IN HUMANS AND BABOONS
Neethling, F. A., & Cooper, D. K. C. (1999) · Transplantation · doi:10.1097/00007890-199903150-00004 · Cited by 32 · cited 1×
“In vitro studies by our group showed this to be the case (Table II) (Koren et al. 1993; Oriol et al. 1993, 1994, 1999; Kujundzic et al. 1994; Neethling et al. 1994, 1996; Neethling and Cooper 1999).”
BackgroundSelf-citationIntracerebral xenotransplantation: recent findings and perspectives for local immunosuppression
Lévêque, X., Cozzi, E., Naveilhan, P., & Neveu, I. (2011) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32834494b5 · Cited by 30 · cited 2×
“Neuronal cells from genetically-engineered pigs may cure neurodegenerative diseases, such as Parkinson’s disease (Leveque et al. 2011).”
BackgroundDons, E. M., Montoya, C. L., Long, C. E., Hara, H., Echeverri, G. J., Ekser, B., Ezzelarab, C., Medellín, D. R., van der Windt, D. J., Murase, N., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e3182481168 · Cited by 29 · cited 2×
“My colleagues and I later confirmed that infant humans and baboons do not make anti-pig (or anti-Gal) antibodies (or anti-A or B antibodies) for the first 3 months or so of life (Neethling et al. 1995; Minanov et al. 1997; Rood et al. 2007; Dons et al. 2012), at which time they begin to develop these antibodies, presu…”
BackgroundSelf-citationGenetically Engineered Pigs as a Source for Clinical Red Blood Cell Transfusion
Cooper, D. K. C., Hara, H., & Yazer, M. H. (2010) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2010.02.001 · Cited by 27 · cited 1×
“The absence of Gal and NeuGc expression on erythrocytes takes us one step closer to being able to use pig red blood cells for transfusion in humans (Rouhani et al. 2004; Cooper et al. 2010; Wang et al. 2014).”
BackgroundSelf-citationThe case for xenotransplantation
Cooper, D. K. C. (2015) · Clinical Transplantation · doi:10.1111/ctr.12522 · Cited by 25 · cited 1×
“…antigens have been deleted and which also express one or more human complementregulatory proteins and one or more human coagulation-regulatory proteins, a clinical trial of kidney or heart xenotransplantation will likely be justified (Cooper 2015; Cooper and Bottino 2015; Cooper et al. 2016).”
BackgroundSelf-citationRouhani, F. J., Dor, F. J. M. F., & Cooper, D. K. C. (2004) · Transfusion · doi:10.1111/j.1537-2995.2004.04002.x · Cited by 25 · cited 1×
“The absence of Gal and NeuGc expression on erythrocytes takes us one step closer to being able to use pig red blood cells for transfusion in humans (Rouhani et al. 2004; Cooper et al. 2010; Wang et al. 2014).”
BackgroundSelf-citationExpression of NeuGc on Pig Corneas and Its Potential Significance in Pig Corneal Xenotransplantation
Lee, W., Miyagawa, Y., Long, C., Ekser, B., Walters, E., Ramsoondar, J., Ayares, D., Tector, A. J., Cooper, D. K. C., & Hara, H. (2016) · Cornea · doi:10.1097/ico.0000000000000635 · Cited by 23 · cited 4×
“Genetically-engineered pigs could also be a source of corneas for the hundreds of thousands of patients worldwide with corneal blindness (Hara and Cooper 2011; Lamm et al. 2014; Lee et al. 2016b).”
BackgroundMethodInfluentialSelf-citationCooper, D. K. C., Koren, E., & Oriol, B. (1996) · Xenotransplantation · doi:10.1111/j.1399-3089.1996.tb00126.x · Cited by 22 · cited 3×
“…synthetic Gal from several different sources (including Nicolai Bovin in Moscow) to test our hypothesis in vivo in baboons (Rieben et al. 1995; Cooper et al. 1996a; Taniguchi et al. 1996b), and indeed found that antibody-mediated rejection of a pig heart was delayed (Simon et al. 1998; Romano…”
BackgroundSelf-citationLi, S. F., Neethling, F. A., Taniguchi, S., Yeh, J.-C., Kobayashi, T., Ye, Y., Koren, E., Cummings, R. D., & Cooper, D. K. C. (1996) · Transplantation · doi:10.1097/00007890-199611150-00026 · Cited by 20 · cited 2×
“In Oklahoma City at that time, we were fortunate to have the advice and collaboration of the well-known glycobiologist, Richard Cummings, with whom we explored other options for obtaining Gal sugars and of reducing antibody binding (Li et al. 1995; Li et al. 1996; Luo et al. 1999).”
BackgroundSelf-citationKuwaki, K., Knosalla, C., Moran, K., Alt, A., Katopodis, A. G., Duthaler, R. O., Schuurman, H., Awwad, M., & Cooper, D. K. C. (2004) · Xenotransplantation · doi:10.1046/j.1399-3089.2003.00096.x · Cited by 19 · cited 4×
“…of anti-Gal antibodies (using immunoaffinity columns of synthetic Gal) in baboons, some of whom subsequently underwent organ or bone marrow transplantation (Kozlowski et al. 1998a, b; Lambrigts et al. 1998; Xu et al. 1998; Watts et al. 2000; Buhler et al. 2001; Kuwaki et al. 2004).”
BackgroundInfluentialSelf-citationGollackner, B., Knosalla, C., Houser, S. L., Mauiyyedi, S., Bühler, L. H., Kawai, T., Duggan, M., Sachs, D. H., Awwad, M., & Cooper, D. K. C. (2003) · Xenotransplantation · doi:10.1034/j.1399-3089.2003.00065.x · Cited by 17 · cited 2×
“We also intravenously infused Gal conjugates (Teranishi et al. 2002a, 2003; Gollackner et al. 2003; Kuwaki et al. 2004).”
BackgroundSelf-citationScreening of baboons as potential liver donors for humans
Luo, Y., Tanlguchi, S., Kobayashi, T., Niekrasz, M., & Cooper, D. K. C. (1995) · Xenotransplantation · doi:10.1111/j.1399-3089.1995.tb00105.x · Cited by 16 · cited 1×
“I initially considered the possibility of using baboons as organ donors for humans (Neethling et al. 1990; Cooper 1992a; Luo et al. 1996).”
BackgroundSelf-citationTeranishi, K., Alwayn, I. P. J., Bühler, L. H., Gollackner, B., Knosalla, C., Huck, J., Duthaler, R. O., Katopodis, A. G., Sachs, D. H., Schuurman, H., et al. (2003) · Xenotransplantation · doi:10.1034/j.1399-3089.2003.02078.x · Cited by 16 · cited 2×
“We also intravenously infused Gal conjugates (Teranishi et al. 2002a, 2003; Gollackner et al. 2003; Kuwaki et al. 2004).”
BackgroundSelf-citationNeethling, F. A., Cooper, D. K. C., Xu, H., & Michler, R. E. (1995) · Transplantation · doi:10.1097/00007890-199509000-00023 · Cited by 15 · cited 2×
“…that infant humans and baboons do not make antipig (or anti-Gal) antibodies (or anti-A or B antibodies) for the first 3 months or so of life (Neethling et al. 1995; Minanov et al. 1997; Rood et al. 2007; Dons et al. 2012), at which time they begin to develop these antibodies, presumably…”
BackgroundSelf-citationGojo, S., Bartholomew, A. M., Xu, Y., Neethling, F. A., Awwad, M., Saidman, S. L., Cosimi, A. B., & Cooper, D. K. C. (2000) · Transplantation · doi:10.1097/00007890-200003150-00042 · Cited by 15 · cited 2×
“2004a), and anti-Gal antibody in various species under differing circumstances (Gojo et al. 2000; Teranishi et al. 2002b).”
BackgroundSelf-citationCooper, D. K. C. (2009) · PubMed · Cited by 15
Self-citationCardiac Allotransplantation Across Major Blood Group Barriers in the Baboon
Cooper, D. K. C., Lexer, G. W., Rose, A. G., Keraan, M., Rees, J., du Toit, E. D., & Oriol, R. (1988) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.1988.tb00197.x · Cited by 15
Self-citationNeutralization of ABO blood group antibodies by specific oligosaccharides.
Romano, E. L., Sóyano, A., Linares, J., & Gj, L. (1987) · Transplantation Proceedings · Cited by 14
Ye, Y., Niekrasz, M., Kehoe, M., Rolf, L. L., Martin, M., Baker, J., Kosanke, S. D., Romano, E., Zuhdi, N., & Cooper, D. K. C. (1994) · PubMed · Cited by 14
Self-citationInhibition of human anti‐αGal IgG by oligosaccharides derived from porcine stomach mucin
Li, S., Yeh, J., Cooper, D. K. C., & Cummings, R. D. (1995) · Xenotransplantation · doi:10.1111/j.1399-3089.1995.tb00109.x · Cited by 12 · cited 1×
“In Oklahoma City at that time, we were fortunate to have the advice and collaboration of the well-known glycobiologist, Richard Cummings, with whomwe explored other options for obtaining Gal sugars and of reducing antibody binding (Li et al. 1995, 1996; Luo et al. 1999).”
BackgroundSelf-citationLack of variation in αgal expression on lymphocytes in miniature swine of different genotypes
Chae, S. J., Kramer, A. D., Zhao, Y. X., Arn, S., Cooper, D. K. C., & Sachs, D. H. (1999) · Xenotransplantation · doi:10.1034/j.1399-3089.1999.00006.x · Cited by 12 · cited 2×
“…(TBRC) at the Massachusetts General Hospital/Harvard Medical School in 1996, we studied Gal expression in different tissues and cell types in pigs (Chae et al. 1999; Gojo et al. 2002; Dor et al. 2004a), and anti-Gal antibody in various species under differing circumstances (Gojo et al. 2000;…”
BackgroundSelf-citationScreening of baboons as potential liver donors for humans.
Luo, Y., Taniguchi, S., Kobayashi, T., Niekrasz, M., & Cooper, D. K. (1996) · PubMed · Cited by 9
Self-citationPreliminary human study of synthetic trisaccharide representing blood substance A.
Romano, E. L., Sóyano, A., & Linares, J. J. G. (1987) · PubMed · Cited by 9
Differential expression of Galα1,3Gal epitopes on fetal and adult porcine hematopoietic cells
Gojo, S., Harper, D., Down, J. D., Awwad, M., & Cooper, D. K. C. (2002) · Xenotransplantation · doi:10.1034/j.1399-3089.2002.01048.x · Cited by 8 · cited 2×
“…General Hospital/Harvard Medical School in 1996, we studied Gal expression in different tissues and cell types in pigs (Chae et al. 1999; Gojo et al. 2002; Dor et al. 2004a), and anti-Gal antibody in various species under differing circumstances (Gojo et al. 2000; Teranishi et al.…”
BackgroundSelf-citationRatites (ostrich, emu) as potential heart donors for humans: immunologic considerations.
Taniguchi, S., Neethling, F. A., Kobayashi, T., Ye, Y., Niekrasz, M., Peters, L., Koren, E., Oriol, R., & Cooper, D. K. (1996) · PubMed · Cited by 8
Self-citationIdentification of αGal as the major target for human anti‐pig antibodies
Cooper, D. K. C. (2009) · Xenotransplantation · doi:10.1111/j.1399-3089.2009.00513.x · Cited by 7 · cited 2×
“Bioprosthetic heart valves from pigs (that are implanted in their thousands each year into patients with cardiac valve disease) will almost certainly function for longer periods if obtained fromGTKO/CMAHKO/β4GalNT2KO pigs (Cooper 2009a; Manji et al. 2014).”
BackgroundSelf-citationInteraction of IgG and IgM anti-A with synthetic oligosaccharides.
Romano, E. L., BHARDWAJ, J., Kelly, S., Olson, M. S., Lamontagne, L. R., Jb, L., & Gj, L. (1987) · PubMed · Cited by 6
Knosalla, C., Giovino, M. A., Harper, D., Kaczmarek, E., Gollackner, B., Cooper, D. K. C., & Robson, S. C. (2003) · Xenotransplantation · doi:10.1111/j.1399-3089.2004.00085.x · Cited by 5 · cited 2×
“I moved to the University of Pittsburgh in 2004 and, around that time and subsequently, several studies were carried out on GTKO pigs (Dor et al. 2004b; Knosalla et al. 2004; Ekser et al. 2012; Fang et al. 2012) and their cells were used for in vitro assays (Ezzelarab et al.”
MethodSelf-citationReichenspurner, H. C., Human, P. A., Rose, A. G., Reichart, B., & Cooper, D. K. (1990) · PubMed · Cited by 5
Self-citationHistocompatibility matching between humans and baboons.
Neethling, F. A., NORTMAN, P. J., & Cooper, D. K. (1990) · Transplantation Proceedings · Cited by 5
Self-citationSmith, A. L., Chinnakotla, S., & Trotter, J. F. (2018) · Springer eBooks · doi:10.1007/978-3-319-64298-7_34 · Cited by 1
THE CHACMA BABOON AS AN ORGAN DONOR FOR MAN
Cooper, D. K. C. (1992) · Transplantation · doi:10.1097/00007890-199206000-00045 · Cited by 1 · cited 3×
“Based on this approach, I was greatly excited when one of the Chembiomed scientists, Heather Good, informed me that a major target for human anti-pig antibodies was the Gal epitope (galactose-α (1,3)-galactose) (Cooper 1992b, 1994; Good et al. 1992; Cooper et al. 1993a; ; Kobayashi and Cooper 1999).”
BackgroundSelf-citation
Research works printed but not linked: 3
- Cooper DKC. 1991. Allo- and xeno- transplantation in non-human primates. Minerva Chirurgica. 46(Suppl. 1 al N. 11):107–116. [Google Scholar]
- Cooper DK, Cairns TD, Taube DH. 1996a. Extracorporeal immunoadsorption of alphaGal antibodies. Xeno. 4:27–29. [Google Scholar]
- Galili U. 1998. Anti-gal antibody prevents xenotransplantation. Sci Med. 5:28–37. [Google Scholar]
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“In pursuit of this difficult goal, ɑ-Galand Neu5Gc-double null pigs have recently been generated (980) (981) (982) (983) .”
BackgroundLong-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion
Kim, S. C., Mathews, D. V., Breeden, C. P., Higginbotham, L. B., Ladowski, J., Martens, G., Stephenson, A., Farris, A. B., Strobert, E. A., Jenkins, J., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15329 · Cited by 232
Extensive germline genome engineering in pigs
Yue, Y., Xu, W., Kan, Y., Zhao, H.-Y., Zhou, Y., Song, X., Wu, J., Xiong, J., Goswami, D., Yang, M., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00613-9 · Cited by 172
Xenotransplantation: past, present, and future
Ekser, B., Li, P., & Cooper, D. K. C. (2017) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000463 · Cited by 112
“Cooper recently published a review on carbohydrate antigen targets on pig cells [101].”
BackgroundSelf-citationThe Role of SLAs in Xenotransplantation
Ladowski, J. M., Hara, H., & Cooper, D. K. C. (2020) · Transplantation · doi:10.1097/tp.0000000000003303 · Cited by 55
Self-citation
Metadata
- Authors
- Cooper, D. K. C.
- Affiliations
- University of Pittsburgh Medical Center (US)
- Corresponding author
- Cooper, David K C
- ORCID
- Cooper, David K C
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03-01
- Volume
- 26
- Issue
- 6
- Pages
- 571-581
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- PMC
- PMC4847619
- OpenAlex
- W2291937681
- Cited by
- 36
- References
- 122
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 2 · 2017: 6 · 2016: 1
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Glycobiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- NIH (U01 AI068642, R21 AI074844, U19 AI090959)
- University of Pittsburgh
- Revivicor, Inc., Blacksburg, VA
- Topics
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Keywords
- xenotransplantation, pig-to-human xenotransplantation, anti-pig antibodies, hyperacute rejection, N-glycolylneuraminic acid, complement activation, coagulation activation, organ shortage
- MeSH terms
- Animals, Antigens, Galactosyltransferases, Graft Rejection, Graft Survival, Humans, Mixed Function Oxygenases, Immunoglobulin G, Immunoglobulin M, Papio, Swine, Transplantation, Heterologous, Transplantation, Homologous, Gene Expression, Organ Transplantation, Gene Deletion, Animals, Genetically Modified
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.